Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T11:33:53.142Z Has data issue: false hasContentIssue false
  • English
  • Français

Do antidepressants cause dependence?

Published online by Cambridge University Press:  11 October 2011

Peter M. Haddad
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 14 , Issue 2 , June 2005 , pp. 58 - 62
Copyright
Copyright © Cambridge University Press 2005

References

REFERENCES

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorder, 4th ed. American Psychiatric Association: Washington DC.Google Scholar
Andersen, H. & Kristiansen, E.S. (1959). Tofranil treatment of endogenous depressions. Acta Psychiatrica Scandinavica 34, 387–397.CrossRefGoogle ScholarPubMed
Bialos, D., Giller, E., Jatlow, P., Docherty, J. & Harkness, L. (1982). Recurrence of depression after discontinuation of amitriptyline. American Journal of Psychiatry 139, 325–329.Google ScholarPubMed
Black, K., Shea, C., Dursun, S. & Kutcher, S. (2000). Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Journal of Psychiatry Neuroscience 25, 255–261.Google ScholarPubMed
Bogetto, F., Bellino, S., Revello, R.B. & Patria, L. (2002). Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs 16, 273–283.CrossRefGoogle ScholarPubMed
Diamond, B.I., Borison, R.L., Katz, R. & DeVeaugh-Geiss, J. (1989). Rebound reactions due to clomipramine. Psychopharmacology Bulletin 255, 209–212.Google Scholar
Fava, M, Mulroy, R., Alpert, J., Nierenberg, A.A. & Rosenbaum, J.F. (1997). Emergence of adverse effects following discontinuation of treatment with extended-release venlafaxine. American Journal of Psychiatry 154, 1760–1762.CrossRefGoogle ScholarPubMed
Frank, E., Kupfer, D.J., Perel, J.M., Comes, C., Jarrett, D.B., Mallinger, A.G., Thase, M.E., McEachran, A.B. & Grochocinski, V.J. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 47 1093–1099.CrossRefGoogle ScholarPubMed
Gardos, G., Cole, J.O. & Tarsy, D. (1978). Withdrawal syndromes associated with antipsychotic drugs. American Journal of Psychiatry 135, 1321–1324.Google ScholarPubMed
Gomez, T.H., Roache, J.D. & Meisch, R.A. (2002). Orally delivered alprazolam, diazepam and triazolam as reinforcers in rhesus mon-keys. Psychopharmacology (Bed) 161, 89–94.Google Scholar
Haddad, P. (1998). The SSRI discontinuation syndrome. Journal of Psychopharmacology 12, 305–313.CrossRefGoogle ScholarPubMed
Haddad, P. (1999). Do antidepressants have any potential to cause addition? Journal of Pychophannacology 13, 300–307.Google Scholar
Haddad, P. & Anderson, I. (1999). Antidepressants aren't addictive: clinicians have depended on them for years. Journal of Psychopharmacology 13, 291–292.CrossRefGoogle ScholarPubMed
Haddad, P.M., Anderson, I. & Rosenbaum, J. (2004). Antidepressant dis-continuation syndromes. In Adverse Syndromes and Psychiatric Drugs; a Clinical Guide (ed. Haddad, P., Dursun, S. and Deakin, B., pp. 183–205. Oxford University Press: Oxford.CrossRefGoogle Scholar
Judge, R., Parry, M.G., Quail, D. & Jacobson, J.G. (2002). Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology 17, 217–225.CrossRefGoogle ScholarPubMed
Law, W., Petti, T.A. & Kazdin, A. (1981). Withdrawal symptoms after gradual cessation of imipramine in children. American Journal of Psychiatry 118, 647–650Google Scholar
Kerr, B. & Myers, P. (1999). Withdrawal syndrome following long-term administration of tamoxifen. Journal of Psychopharmacology 13, 419.CrossRefGoogle ScholarPubMed
Keyser, D.L. & Rodnitzky, R.L. (1991). Neuroleptic malignant syndrome in Parkinon's disease after withdrawal or alteration of dopaminergic therapy. Archives of Internal Medicine 151, 794–796.CrossRefGoogle ScholarPubMed
Mann, A.M. & MacPherson, A (1959). Clinical experience with imipramine (G22355) in the treatment of depression. Canadian Psychiatric Association Journal 4, 38–47.CrossRefGoogle ScholarPubMed
Medawar, C. (1997). The Antidepressant Web - marketing depression and making medicines work. International Journal of Risk and Safety Medicine 10, 75–126.CrossRefGoogle Scholar
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R. & Tepner, R.G., (2000). Interruption of selective serotonin reup-take inhibitor treatment. Double-blind, placebo-controlled trial. British Journal of Psychiatry 176, 363–368.CrossRefGoogle Scholar
Nutt, D. (2003). Death and dependence: current controversies over the selective serotonin reuptake inhibitors. Journal of Psychopharmacology 17, 355–364.CrossRefGoogle ScholarPubMed
Oehrberg, S., Christiansen, P.E., Behnke, K., Borup, A.L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J.K. & Manniche, P.M. (1995). Paroxetine in the treatment of panic disorder. A randomized, double-blind, placebo-controlled study. British Journal of Psychiatry 167, 374–379.CrossRefGoogle Scholar
Price, J.S., Waller, P.C., Wood, S.M & MacKay, A.V. (1996). A comparison of the post-marketing safety of four selective serotonin reuptake inhibitors, including the investigation of symptoms occurring on withdrawal. British Journal of Clinical Pharmacology 42, 757–763.CrossRefGoogle ScholarPubMed
Rosenbaum, J.F., Fava, M., Hoog, S.L., Ascroft, R.C. & Krebs, W.B. (1998). Selective serotonin reuptake inhibitor discontinuation syndrome: a randomised clinical trial. Biological Psychiatry 44, 77–87.CrossRefGoogle Scholar
Routledge, P.A. & Bialas, M.C. (1997). Adverse reactions to drug withdrawal. Adverse Drug Reaction Bulletin 187, 711–714.CrossRefGoogle Scholar
Schindler, C.W., Panlilio, L.V. & Goldberg, S.R. (2002). Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl.) 163, 327–344.CrossRefGoogle ScholarPubMed
Tint, A.K., Haddad, P.M., Anderson, I.M. & Tiplady, B. (2002). SSRI/venlafaxine discontinuation symptoms during antidepressant switching: an interim analysis. Journal of Psychopharmacology, Suppl. 16(3), A44.Google Scholar
Tranter, R. & Healy, D. (1998). Neuroleptic discontinuation syndromes. Journal of Psychopharmacology 12, 401–406.CrossRefGoogle ScholarPubMed
Tyrer, P. (1984). Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long term treatment. Journal of Affective Disorders 6, 1–7.CrossRefGoogle ScholarPubMed
Tyrer, P. (1999). Stress diathesis and pharmacological dependence. Journal of Psychopharmacology 13, 294–295.CrossRefGoogle ScholarPubMed
World Health Organization (1992). The 1CD-10 Classification of Mental and Behavioural Disorders. World Health Organization: Geneva.Google Scholar